Dissolving Microneedle Market

Dissolving Microneedle Market Outlook from 2024 to 2034

The global dissolving microneedles industry is culminating to reach USD 118.5 million by 2034 from USD 47.2 million in 2024. Throughout this period, the market is expected to register a promising CAGR of 9.6%.

Key Highlights:

• The lower manufacturing cost of dissolving microneedles compared to other microneedles available in the market, is augmenting their sales.
• The increasing needle-phobic population is raising the demand for comfortable and less invasive drug delivery methods via skin. As a result, people are opting for dissolving microneedles that are tiny and cause no harm to any dermal nerve or blood vessel.
• The surging use of dissolving microneedles to administer vaccines is becoming a popular painless vaccination technique.
• From an ecological point of view, soluble microneedles considerably reduce the generation of hazardous medical waste. Thus, contributing to the vision of a greener planet.

Attributes	Details
Dissolving Microneedle Market Size (2024)	USD 47.2 million
Dissolving Microneedle Market Forecasted Size (2034)	USD 118.5 million
Projected Value CAGR (2024 to 2034)	9.6%

Dissolving Microneedle Market Trends and Opportunities

Attributes	Details
Trends	Increasing research and development to enhance the efficacy and expand the applications of dissolving microneedles. In addition to this, the surging use of dissolving microneedles in acne treatments, undereye patches, and as an alternative to derma rolling is projected to propel market growth. Soko Glam, Inc., for instance, has developed a product called Acropass Trouble Cure that uses a unique dissolving microneedle technology to deliver substances painlessly and efficiently. Customization of the clinical treatments provided via dissolving microneedles like the depth of these needles and the presence of active chemicals to effectively treat the skin condition is influencing the market growth.
Opportunities	In this digital space, there are breakthrough opportunities for manufacturers of dissolving microneedles. A related futuristic use of dissolving microneedles is in digital medicine. By developing convergence systems that offer information on drug loading amounts, controlled release rates, and patch change intervals, advanced usage of dissolving microneedles can change the face of drug administration. In future, the use of dissolvable microneedles in the pharmaceutical sector is expected to be more openly explored. Companies are striving for better treatment for health conditions like osteoporosis, Alzheimer's disease, and others, which often require a once-daily injection. Thus, the introduction of these less invasive needles in the pharma sector is expected to give hope for a better quality of life.

Dissolving Microneedle Industry Analysis by Region

The scope of dissolving microneedles is lucrative in Europe, owing to inflating discretionary income and a high degree of willingness for cosmetic treatments. Two important places where demand and sales of dissolving microneedles are predicted to be high are Germany and the United Kingdom. Meanwhile, North America is expected to register a comparatively lower demand for dissolving microneedles.

Consumption of this instrument is predicted to expand on account of the rising concentration of manufacturers, amplified marketing, and increasing desire to undergo minimally invasive aesthetic procedures, and continuous advancements.

The promising growth of dissolving microneedle business in the Asia Pacific is predicted to propel investors and stakeholders to increase their stake in this region. The significant influence of the West is predicted to be a key catalyst for the sales of dissolving microneedles for aesthetic purposes. Additionally, increasing the use of these needles for the transdermal delivery of several drugs is predicted to advance the regional market.

Country	Forecasted CAGR (2024 to 2034)
The United States	9.6%
Germany	14.1%
The United Kingdom	12.8%
China	10.7%
Japan	10.2%

The United States is Witnessing Rising Use of Dissolving Microneedles to Deliver Drugs

The United States dissolving microneedle market is expected to lead in North America by a substantial market share. As per the latest estimates by FMI analysts, the market in the United States is projected to register a promising 9.6% CAGR through 2034. Following factors back this growth:

• Surge in consumer spending on cosmetic treatments like acne treatment and wrinkle treatment.
• Increasingly occurring skin diseases in the country.
• Advancing technology of dissolving microneedles allowing it to be used to administer various medications directly into the skin. In 2020, for instance, microneedles were used to deliver viral proteins into the skin to induce an immune response by the University of Connecticut, Vaxess, and Verndari.
• Rising investments in research and development activities to increase the applications of dissolving microneedles.
• Growing concentration of leading manufacturers in the United States.

Dissolving Microneedle Manufacturers Find More Openness for These Instruments in Germany

Germany is a notable market for dissolving microneedles in Europe. The country is estimated by FMI analysts to record an impressive CAGR of 14.1% through 2034. Key factors that are driving this growth are:

• Increasing use of dissolving microneedles to efficiently enhance dermal drug delivery.
• Significant progress made by dissolving microneedles in the field of vaccine delivery, disease diagnosis, and monitoring.
• This instrument exhibits significant potential in clinical treatment. Therefore, manufacturers in the country are investing and increasing their capacity to make full use of this latent opportunity.
• Some common factors that are propelling market growth include the expanding geriatric population, rising patient awareness, and increasing healthcare infrastructure.

Versatility of Dissolving Microneedles in Raising its Application in the United Kingdom

Consumption of dissolving microneedles in the United Kingdom is predicted to shoot up at a CAGR of 12.8% through 2034. Given below are some of the salient growth factors:

• Surging use of dissolving microneedles for the transdermal delivery of several drugs as they are emerging as a versatile drug delivery system.
• Key players in the country are undertaking strategic initiatives like agreements, partnerships, collaboration, and others.
• Increasing market for dissolving microneedles as patients of infectious and chronic diseases is rising at a consistent rate.

Growing Preference for Modern Therapeutic Methods in China is Cultivating a Market for Dissolving Microneedle

The dissolving microneedle market in China is expected to surge at a compounded rate of 10.7% through 2034. The adoption of dissolving microneedles is driven by:

• Accelerating use of dissolving microneedles to deliver drugs into the patient’s body.
• Frequent use of dissolving microneedles in aesthetic procedures like hair development and skin care.
• Emerging demand for cutting-edge therapeutic and medical methods among consumers in China is increasing investments in dissolving microneedles.

Commercialization of Advanced Dissolving Microneedles in Japan Elevating the Market Scope

In Japan, the consumption of dissolving microneedles is projected to increase at a CAGR of 10.2%. The market is supported by following factors:

• Increasing commercialization of dissolving microneedles in Japan is enhancing the market scope in the country.
• Surging rate of skin disorders in the country.
• Rising demand for cutting-edge dermal acne patches.

Dissolving Microneedle Industry Analysis by Segment

Dissolving Microneedles are Becoming a Popular Choice in the Wrinkle Treatment

Attributes	Details
Top Application	Wrinkle Treatment
Market Share in 2024	85.3%

As per the latest dissolving microneedle market research report, the wrinkle treatment is estimated to acquire a massive value share of 85.3% in 2024. Key factors that are propelling market growth are as follows:

• Growing interest of population in treatments that promise youthful and glowing skin, as well as prevention of signs of aging is increasing this segment’s growth. Booming anti-aging market is increasing the application of dissolving microneedles for its minimal invasion and effective treatment.
• High efficacy of dissolving microneedle is increasing its use in wrinkle treatment. These needles once injected into the skin, trigger the production of elastin and collagen and give the skin its elasticity and plumpness. Thus, reducing the appearance of wrinkles and fine lines.

Online Stores are the Preferred Distribution Channel for Buying Dissolving Microneedle

Attributes	Details
Top Distribution Channel	Online Stores
Market Share in 2024	41.0%

Online stores segment is projected to procure a market share of 41.0% in 2024. Top factors that are predicted to expand the market growth are as follows:

• Increasing smartphone ownership and rising internet penetration are contributing to heightened sales of dissolving microneedles via online platforms owing to easy accessibility and convenience.
• Growing segment of consumers who prefer discreetness and privacy are hopping onto the online channel, especially for concerns like facial rejuvenation and wrinkle reduction. These platforms offer a convenient environment to undergo such treatments without public exposure.
• Consumers prefer online stores due to the greater transparency provided by them, thus fostering trust and encouraging customers to make purchases from online mediums.

Top Growth Strategies for the Dissolving Microneedle Market Players in 2024 and Beyond

Several strategies have been devised to help businesses and manufacturers bump up their position in the dissolving microneedle industry. Some of these strategies have been outlined below:

• Diversification of dissolving microneedle offerings beyond primary applications like wrinkle treatment into fields like pain management, vaccine delivery, and chronic disease monitoring.
• Improvement of microneedle designs to enhance drug delivery, elevate user comfort, and target certain skin layers.
• Increase investment in the research of biocompatible and biodegradable materials with improved functionality and safety.
• Capturing new markets in emerging economies that have significant growth potential.
• Strengthening distribution channel of dissolving microneedle by offering them via direct-to-consumer models, online platforms, and partnerships with beauty retailers and pharmacies.

Recent Developments in the Dissolving Microneedle Market

• In 2024, CD Formulation, a contract pharmaceutical formulation development services, declared that it is introducing dissolving microneedle preparation services. This competitive innovation in drug delivery technology offers to revolutionize the healthcare sector and enhance the efficiency and patient comfort.
• Raphas Co., Ltd., in February 2022, reportedly formed a research partnership with Johnson & Johnson to bring progress in skin health solutions. The partnership is aimed at exclusively developing and applying microneedle particles, made of Raphas’ patented Droplet Extension (DEN) technology in skin care products.
• Vice Reversa, which is a next-Gen precision skincare firm, announced in October 2021 that it is investing to expand the company’s geographical presence.

Key Dissolving Microneedle Manufacturers

• CosMED Pharmaceutical Co.Ltd.
• Micron Biomedical, Inc.
• Raphas Co., Ltd
• Nissha Co., Ltd
• Micropoint Technologies
• Small Lab
• Vice Reversa
• NINGBO CHIMED TECHNOLOGY CO., LTD
• Vaxess Technologies, Inc.
• QuadMedicine
• Others

Table of Content

• 1. Executive Summary
• 2. Market Overview
• 3. Market Background
• 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
• 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application
  • 5.1. Wrinkle Treatment
  • 5.2. Acne Treatment
• 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel
  • 6.1. Retail Stores
  • 6.2. Supermarkets & Hypermarkets
  • 6.3. Online Stores
  • 6.4. Aesthetic/Cosmetic Clinics
• 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
  • 7.1. North America
  • 7.2. Latin America
  • 7.3. Western Europe
  • 7.4. Eastern Europe
  • 7.5. South Asia and Pacific
  • 7.6. East Asia
  • 7.7. Middle East and Africa
• 8. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 9. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 10. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 11. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 12. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 13. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 14. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 15. Key Countries Market Analysis
• 16. Market Structure Analysis
• 17. Competition Analysis
  • 17.1. CosMED Pharmaceutical Co.Ltd.
  • 17.2. Micron Biomedical, Inc.
  • 17.3. Raphas Co., Ltd
  • 17.4. Nissha Co., Ltd
  • 17.5. Micropoint Technologies
  • 17.6. Vice Reversa
  • 17.7. NINGBO CHIMED TECHNOLOGY CO., LTD
  • 17.8. Vaxess Technologies, Inc.
  • 17.9. QuadMedicine
• 18. Assumptions & Acronyms Used
• 19. Research Methodology